Literature
首页医源资料库在线期刊美国临床营养学杂志2001年74卷第2期

Total parenteral nutrition: potion or poison?

来源:《美国临床营养学杂志》
摘要:ABSTRACTTheroleofnutritionalsupportinclinicalcarehasburgeonedoverthepast40y。Initially,totalparenteralnutri-tion(TPN)wasconsideredtobethestandardofcare。Later,theconceptthatenteralnutrition(EN)promotedgutfunctionandpreventedthetranslocationofintestinalb......

点击显示 收起

Khursheed N Jeejeebhoy1

From the University of Toronto and St Michael's Hospital, Toronto.

See corresponding editorial on page 153.

2 Supported by MRC grant MT-10885.

3 Address reprint requests to KN Jeejeebhoy, 3-035 Queen Wing, St Michael's Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8. E-mail: khush.jeejeebhoy{at}utoronto.ca.


ABSTRACT  
The role of nutritional support in clinical care has burgeoned over the past 40 y. Initially, total parenteral nutri-tion (TPN) was considered to be the standard of care. Later, the concept that enteral nutrition (EN) promoted gut function and prevented the translocation of intestinal bacteria resulted in EN becoming the standard of care. Furthermore, TPN was consid-ered to be a dangerous form of therapy. Critical review of the data suggests that, in humans, TPN does not cause mucosal atro-phy or increase bacterial translocation. Increased sepsis with TPN can be ascribed to overfeeding; the dangers of TPN-induced complications have been exaggerated. TPN is an equally effec-tive alternative to EN when a risk of malnutrition is present and EN is not tolerated or when gut failure is present.

Key Words: Total parenteral nutrition • enteral nutrition • TPN • EN • nutritional support • malnutrition • review


INTRODUCTION  
Gastrointestinal diseases often prevent adequate nutrition because of associated malabsorption, anorexia, and an inability to eat without discomfort. In addition, several disease states, such as sepsis, trauma, and cancer, alter nutrient utilization, resulting in loss of body weight and wasting. These phenotypic effects are similar to those observed with malnutrition caused by an inadequate food intake. About 40 y ago the role of malnutrition in the above-mentioned conditions was recognized to be associated with increased morbidity and mortality in hospitalized patients. This realization resulted in the development of total parenteral nutrition (TPN) and the philosophy that if some nutrition is good, more is better, and the coining of the term hyperalimentation. A flurry of studies then appeared in the literature extolling the virtues of superfeeding through a central venous catheter in promoting recovery from conditions ranging from anorexia to cancer. However, this enthusiasm gave way to reality when it became obvious from controlled studies that not only did TPN not cure cancer, but it also increased complications under certain circumstances.

In another development, the concept of bacterial translocation through the injured and malnourished intestine was raised as the cause of the sepsis resulting in multisystem organ failure in critically ill patients. It was hypothesized that, by not feeding the intestinal tract, TPN caused atrophy of the intestine, resulted in increased bacterial translocation, and promoted sepsis. A series of studies suggested that feeding nutrients through the intestinal tract prevented this sepsis and resulted in less morbidity and mortality than did TPN.

Thus, the pendulum has now swung the other way and a flurry of studies and meta-analyses in the literature have characterized TPN as a poisonous form of therapy and have extolled the virtues of enteral nutrition (EN), or tube feeding, as a panacea of all ills. In this review, I critically examine the relative merits of EN and TPN.


PARENTERAL NUTRITION COMPARED WITH STANDARD CARE  
Gut failure
Before the availability of TPN, severe malnutrition leading to increased morbidity and mortality was documented in patients with extensive intestinal resection. Several publications showed that these patients can lead useful lives with use of TPN at home (1–3).

Critical illness
Heyland et al (4) performed a meta-analysis of 26 randomized controlled trials in which TPN was compared with standard care. These trials included 2211 patients undergoing surgery, patients with burns, patients with pancreatitis, and patients in the intensive care unit. Although TPN did not reduce mortality and overall morbidity, Heyland et al found that it significantly reduced morbidity in malnourished patients.

To show that TPN reduces complications, it must be studied in patients in whom complications are increased; attempting to measure a difference in complications when the complication rate is already very low is a statistical nonstarter. Naber et al (5) showed that malnutrition increases the risk of morbidity in hospitalized patients. Therefore, it is not surprising that the only benefit of TPN seen was in malnourished patients.

By pooling data from 13 randomized controlled trials involving 1100 patients, Twomey [in Klein et al (6)] showed that there was a 10% reduction in risk of complications in patients receiving preoperative TPN, but that postoperative TPN increased complications. In a well-controlled trial of preoperative TPN in patients undergoing hepatectomy, preoperative TPN reduced the incidence of overall complications, sepsis, and diuretic use (7). Note that in this trial, sepsis was reduced. In contrast, in a Veterans' Administration trial, the use of preoperative TPN increased the risk of sepsis (8), but a further analysis in a subgroup from that trial showed that malnourished patients receiving TPN had fewer nonseptic complications. Finally, in a trial of only malnourished patients, Bozzetti et al (9) found that TPN reduced noninfectious complications and did not increase sepsis.


THEORY OF THE BENEFITS OF ENTERAL NUTRITION  
Prevents mucosal atrophy
Enteral nutrition is believed to be beneficial because it protects the gut from mucosal atrophy. This concept was developed from the results of animal studies showing that the administration of TPN resulted in significant intestinal villus atrophy within a few days (10). However, human studies have not shown any intestinal atrophy with complete bowel rest and TPN, even 1 mo after the withdrawal of food by mouth (Table 1). Atrophy was observed only when TPN was given to children for several months, during which time the children did not receive any food by mouth.


View this table:
TABLE 1.. Total parenteral nutrition (TPN) and intestinal atrophy in humans1  
Prevents bacterial translocation
Rigorous studies were performed in human subjects in which bacterial translocation from the intestine was identified by culturing the same organism in the blood as in the intestine and the mesenteric lymph nodes. These studies showed that translocation occurs, especially in patients with intestinal obstruction, but that its incidence is no different between patients receiving TPN or EN (16). Even most trauma patients did not have septicemia from organisms found in the gut and only 2 of 132 patients had translocation (17). In summary, therefore, there is little evidence in humans that TPN causes atrophy of the intestinal mucosa and that EN prevents bacterial translocation.


NUTRIENTS AND SEPSIS  
Although it is true that progressive starvation will ultimately lead to death and that malnutrition is associated with an increased risk of complications, the available trials have not clearly shown that artificial nutrition reduces complications or mortality. On the other hand, these trials did not specifically select patients with severe weight loss, ie, those most likely to show benefit from nutritional support or to die from starvation. Furthermore, it is not as well recognized that in the presence of sepsis an increased intake of energy (carbohydrates or fats) increases the risk of complications (18). The risk of complications with increased energy intake is especially associated with the development of hyperglycemia (19), and hyperglycemia tends to occur in septic patients who are insulin resistant. The possible mechanism of increased complications induced by increased energy intake is an increase in the expression of tumor necrosis factor receptors (20) associated with an increase in nuclear factor B binding to the nucleus (N Raina and KN Jeejeebhoy, unpublished observations, 2000). Furthermore, in septic guinea pigs, increased energy intake caused an increase in mortality (21). In animals infused with tumor necrosis factor, simply feeding sufficient energy to promote normal growth caused increased complications (22).

The trials comparing EN and TPN should be examined with a view toward determining whether the nutritional support was comparable in terms of energy intake. Excess energy intake with either EN or TPN influences the risk of sepsis.


ENTERAL COMPARED WITH PARENTERAL NUTRITION: OUTCOME ANALYSIS  
Pancreatitis
McLave et al (23) randomly assigned 32 patients to receive either TPN or EN and observed no significant differences in rates of infection or morbidity. Windsor et al (24) randomly assigned 34 patients with acute pancreatitis to either TPN or EN and observed no significant differences in incidence of sepsis, length of hospital stay, computerized tomography scores, or organ failure. Kalfarentzos et al (25) randomly assigned 38 patients to either EN or TPN and showed that patients receiving TPN had a higher incidence of sepsis. However, twice the number of patients receiving TPN were hyperglycemic and therefore the difference in increased energy intake and hyperglycemia may explain the increased sepsis with TPN. On the other hand, administration of TPN did not increase the length of stay in the intensive care unit or in the hospital. Giving TPN also did not increase the need for antibiotics or ventilator support.

Inflammatory bowel disease
In a randomized controlled trial comparing TPN with EN or TPN given together with an oral diet in patients with Crohn disease, no increased complications were observed as a result of TPN, and the rate of remission between the 2 modalities of Crohn disease was the same (26). In patients with acute colitis it was shown that TPN resulted in an increased rate of sepsis; however, other complications such as the rate of colectomy or remission of disease activity were not significantly different between the 2 groups (27). In that trial, however, only 44 of 82 patients were studied and very sick patients were excluded, biasing the results.

Trauma
In a study of nutritional support after major abdominal trauma, Moore et al (28) randomly assigned 29 patients to EN and 30 patients to TPN. The investigators found a significantly increased incidence of sepsis in patients receiving TPN. However, patients given TPN received significantly more energy and had higher concentrations of plasma glucose than did patients given EN. They also had significantly increased concentrations of plasma insulin, suggesting that they were overfed. Kudsk et al (29) randomly assigned 98 patients to either EN or TPN; again, in this study, the patients given TPN received significantly more energy. The patients randomly assigned to TPN who had high injury severity scores or high abdominal trauma index scores had increased sepsis. Despite the increased sepsis rate, patients receiving TPN did not receive more antibiotics nor did they remain longer in hospital.

Sepsis
Cerra at al (30) randomly assigned 66 patients who were septic and hypermetabolic to EN or TPN and found that there was no significant difference in the incidence of multisystem organ failure or death between the 2 groups.

Procedure-related complications
In theory, it would be expected that procedure-related complications would be much greater in patient receiving TPN because of catheter-related problems. However, in 7 of 9 randomized trials of EN compared with TPN in which procedure-related complications were reported, the incidence was higher during EN (31).

Conclusion
TPN is the form of nutritional support most suited to patients with gut failure, in whom it is lifesaving. It is obviously beneficial when malnutrition is present in several clinical conditions. On the other hand, overfeeding, which can easily occur with TPN, increases complications—especially sepsis. There is little evidence that several processes described in animals and ascribed to TPN, such as intestinal atrophy and increased bacterial translocation, occur in humans. Unlike the general belief, TPN undertaken by experienced teams does not cause more complications than does EN. In fact, it appears that TPN is associated with fewer procedure-related complications. In short, when indicated because of the inability to give EN, TPN is beneficial in the treatment of malnutrition but is not a cure for all illnesses. These conclusions are supported by the results of a recent 562-patient trial of EN compared with TPN that concluded that TPN did not increase sepsis, EN delivered less than the target nutritional intake, and the procedure-related complications were greater with EN (32).


REFERENCES  

  1. Jeejeebhoy KN, Zohrab WJ, Langer B, Phillips MJ, Kuksis A, Anderson GH. Total parenteral nutrition at home for 23 months without complication and with good rehabilitation. A study of technical and metabolic features. Gastroenterology 1973;65:811–20.
  2. Howard L, Hassan N. Home parenteral nutrition. 25 years later. Gastroenterol Clin North Am 1998;27:481–512.
  3. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043–50.
  4. Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient. A meta-analysis. JAMA 1998;280: 2013–9.
  5. Naber THJ, Schermer T, de Bree A, et al. Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 1997;66:1232–9.
  6. Klein S, Kinney J, Jeejeebhoy KN, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997;66:683–706.
  7. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994;331:1547–52.
  8. VA TPN Cooperative Study. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991;325:525–32.
  9. Bozzetti F, Gavazzi C, Miceli R, et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr 2000;24:7–14.
  10. Miura S, Tanaka S, Yoshioka M, et al. Changes in intestinal absorption of nutrients and brush border glycoproteins after total parenteral nutrition in rats. Gut 1992;33:484–9.
  11. Guedon C, Schmitz J, Lerebours E, et al. Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology 1986;90:373–8.
  12. Rossi TM, Lee PC, Young C, Tjota A. Small intestinal mucosa changes, including epithelial cell proliferative activity, of children receiving total parenteral nutrition (TPN). Dig Dis Sci 1993;38: 1608–13.
  13. Pironi L, Paganelli GM, Miglioli M, et al. Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection. JPEN J Parenter Enteral Nutr 1994;18:351–4.
  14. Sedman PC, MacFie J, Palmer MD, Mitchell CJ, Sagar PM. Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br J Surg 1995;82:1663–7.
  15. Groos S, Hunefeld G, Luciano L. Parenteral versus enteral nutrition: morphological changes in human adult intestinal mucosa. J Submicrosc Cytol Pathol 1996;28:61–74.
  16. Sedman PC, MacFie J, Sagar P, et al. The prevalence of gut translocation in humans Gastroenterology 1994;107:643–9.
  17. Moore FA, Moore EE, Poggetti RS, Read RA. Postinjury shock and early bacteremia. A lethal combination. Arch Surg 1992;127:893–7.
  18. Zaloga GP, Roberts P. Permissive underfeeding. New Horiz 1994;2: 257–63.
  19. Golden SH, Linda Kao WH, Peart-Vigilance C, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999;22:1408–14.
  20. Raina N, LaMarre J, Liew C-C, Lofti AH, Jeejeebhoy KN. Effect of nutrition on the expression of plasma soluble tumor necrosis factor (TNF) receptors, membrane TNF receptors and mRNA of TNF receptors in rats receiving oral and parenteral nutrition. Am J Physiol 1999;277:E464–73.
  21. Yamazaki K, Maiz A, Moldawer LL, Bistrian BR, Blackburn GL. Complications associated with overfeeding of infected animals. J Surg Res 1986;40:152–8.
  22. Matsui J, Cameron RG, Kurian R, Kuo GC, Jeejeebhoy KN. Nutritional, hepatic, and metabolic effects of cachectin/tumor necrosis factor in rats receiving total parenteral nutrition. Gastroenterology 1993;104:235–43.
  23. McLave SA, Greene LM, Snider HL, et al. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis. JPEN J Parenter Enteral Nutr 1997;21:14–20.
  24. Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998;42:431–5.
  25. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized trial. Br J Surg 1997;84:1665–9.
  26. Greenberg GR, Fleming CR, Jeejeebhoy KN, Rosenberg IH, Sales D, Tremaine WJ. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988;29:1309–15.
  27. Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M, et al. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 1993;88:227–32.
  28. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma 1989;29:916–23.
  29. Kudsk KA, Croce MA, Fabian TC, et al. Enteral versus parenteral feeding. Ann Surg 1992;215:503–13.
  30. Cerra FB, McPherson JP, Konstantinides FN, Konstantinides NN, Teasley KM. Enteral nutrition does not prevent multiple organ failure syndrome (MOSF) after sepsis. Surgery 1988;104:727–33.
  31. Lipman TO. Grains or veins: is enteral nutrition really better than parenteral nutrition? A look at the evidence. JPEN J Parenter Enteral Nutr 1998;22:167–82.
  32. Woodcock NP, Zeigler D, Palmer MD, Buckley P, Mitchell CJ, MacFie J. Enteral versus parenteral nutrition: a pragmatic study. Nutrition 2000;17:1–12.
Received for publication January 2, 2001. Accepted for publication February 22, 2001.


作者: Khursheed N Jeejeebhoy1
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具